Position in OGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,785,500
+$7,785,171 QoQ
Shares Held
575,000
+1045354.5% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#59
of 630 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $130,004,533 across 10 Drug Manufacturers - General names. OGN ranks #6 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
33,628 | $40,334,435 | |
| 2 | JNJ |
Johnson & Johnson
|
96,594 | $24,531,978 | |
| 3 | MRK |
Merck & Co., Inc.
|
176,844 | $22,724,454 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
119,118 | $15,049,368 | |
| 5 | BIIB |
Biogen Inc.
|
46,536 | $10,054,568 | |
| 6 | OGN |
Organon & Co.
This page
|
575,000 | $7,785,500 | |
| 7 | ABBV |
AbbVie Inc.
|
25,497 | $6,416,065 | |
| 8 | AZN |
Astrazeneca PLC
|
13,330 | $2,527,634 |
All Filings in OGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,785,500 | 575,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $329 | 55 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $394 | 55 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1 | 55 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1 | 55 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $20,458 | 1,374 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1 | 55 | Shares | Sole | 2025-04-02 | |
| 2024-09-30 | $1,052 | 55 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||